Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy

NCT00358124 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00358124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00358124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2001
Completion date
June 30, 2002
Enrollment
220
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus